Abstract
Glycosylation is one of the major post-translational modifications, required for proper folding and functions of glycoproteins. N-glycosylation in ER is mediated by oligosaccharyltransferase (OST), an enzyme complex transferring preassembled oligosaccharide to asparagine residues of nascent polypeptide chain. Our study here indicates that regulator of calcineurin 1 (RCAN1) can enhance N-glycosylation in ER, therefore elevates the activities of β- and γ-secretase and markedly increases Aβ production. We found that RCAN1 stabilizes OST by interacting with OST component ribophorinI (RPN I). RCAN1 enhanced glycosylation of membrane proteins and glycosylation sequon GNSTVT, but has no effect on transferrin whose glycosylation was only affected by OST catalytic subunit STT3A, suggesting the effect of RCAN1 is associated with RPN I in facilitating substrate delivery. Our previous studies have shown that RCAN1 was increased in AD brains and RCAN1 overexpression induced neuronal apoptosis. Here our study showed that RCAN1 further contributes to AD pathogenesis by increasing N-glycosylation and Aβ production.
Keywords: Aβ, Alzheimer’s disease, β-secretase, γ-secretase, N-glycosylation, oligosaccharyltransferase, RCAN1.
Current Alzheimer Research
Title:RCAN1 Increases Aβ Generation by Promoting N-glycosylation via Oligosaccharyltransferase
Volume: 11 Issue: 4
Author(s): Tan Wang, Heng Liu, Yun Wang, Changqing Liu and Xiulian Sun
Affiliation:
Keywords: Aβ, Alzheimer’s disease, β-secretase, γ-secretase, N-glycosylation, oligosaccharyltransferase, RCAN1.
Abstract: Glycosylation is one of the major post-translational modifications, required for proper folding and functions of glycoproteins. N-glycosylation in ER is mediated by oligosaccharyltransferase (OST), an enzyme complex transferring preassembled oligosaccharide to asparagine residues of nascent polypeptide chain. Our study here indicates that regulator of calcineurin 1 (RCAN1) can enhance N-glycosylation in ER, therefore elevates the activities of β- and γ-secretase and markedly increases Aβ production. We found that RCAN1 stabilizes OST by interacting with OST component ribophorinI (RPN I). RCAN1 enhanced glycosylation of membrane proteins and glycosylation sequon GNSTVT, but has no effect on transferrin whose glycosylation was only affected by OST catalytic subunit STT3A, suggesting the effect of RCAN1 is associated with RPN I in facilitating substrate delivery. Our previous studies have shown that RCAN1 was increased in AD brains and RCAN1 overexpression induced neuronal apoptosis. Here our study showed that RCAN1 further contributes to AD pathogenesis by increasing N-glycosylation and Aβ production.
Export Options
About this article
Cite this article as:
Wang Tan, Liu Heng, Wang Yun, Liu Changqing and Sun Xiulian, RCAN1 Increases Aβ Generation by Promoting N-glycosylation via Oligosaccharyltransferase, Current Alzheimer Research 2014; 11 (4) . https://dx.doi.org/10.2174/1567205011666140331225855
DOI https://dx.doi.org/10.2174/1567205011666140331225855 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Thematic Issue : What is Language? Different Viewpoints)
Neuroscience and Biomedical Engineering (Discontinued) Patent Selections:
Recent Patents on Chemical Engineering How Does Pain Induce Negative Emotion? Role of the Bed Nucleus of the Stria Terminalis in Pain-Induced Place Aversion
Current Molecular Medicine <i>Nigella sativa</i> – A Functional Spice From A Pharaoh’s Tomb to Modern Healthcare
The Natural Products Journal Microwave-Assisted Chemistry of 2(1H)-pyrazinones
Current Organic Chemistry Synthesis and Antimicrobial Activity of Adamantyl Substituted Pyridoxine Derivatives
Letters in Drug Design & Discovery Calcium Ion – The Key Player in Cerebral Ischemia
Current Medicinal Chemistry The Phosphodiesterase III Inhibitor Cilostazol Ameliorates Ethanolinduced Endothelial Dysfunction
Current Neurovascular Research Immunophilins and Coupled Gating of Ryanodine Receptors
Current Topics in Medicinal Chemistry Structural and Functional MRI in Mild Cognitive Impairment
Current Alzheimer Research Cellular Signalling Pathways of Spinal Pain Neuroplasticity as Targets for Analgesic Development
Current Topics in Medicinal Chemistry Editorial [Hot Topic: De-risking the Discovery and Development of New Drugs from Bench to Clinic (Guest Editor: Sergey Ilyin)]
Current Topics in Medicinal Chemistry Indoles - Gut Bacteria Metabolites of Tryptophan with Pharmacotherapeutic Potential
Current Drug Metabolism Placental Cytokines in the Pathogenesis of Preeclampsia and Hellp Syndrome
Current Women`s Health Reviews Conference Report
CNS & Neurological Disorders - Drug Targets M2 Protein-A Proton Channel of Influenza A Virus
Current Pharmaceutical Design Parasite Prolyl Oligopeptidases and the Challenge of Designing Chemotherapeuticals for Chagas Disease, Leishmaniasis and African Trypanosomiasis
Current Medicinal Chemistry Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives
Current Medicinal Chemistry Current Experimental Therapy for Alzheimers Disease
Current Neuropharmacology Drug Metabolism and Drug Interactions: Application and Clinical Value of In Vitro Models
Current Drug Metabolism